Breaking News Stories

DEA warns widespread ‘Tranq’ mixture makes fentanyl even deadlier; cases ‘not prevalent’ in Nevada

An illegal drug was found in a Fordham Manor apartment in the Bronx to create the dangerous skin-eating drug “tranq” mixed with xylazine, law enforcement officers told PIX11 News. (Credit: NYC Special Drug Prosecutor’s Office)

LAS VEGAS (KLAS) — This week’s new public safety alert from the Drug Enforcement Administration (DEA) confirms that xylazine — commonly known as “Tranq” — has spread across the country, potentially causing serious illness to people. It warns that it poses a health risk. receive without knowing

“Xylazine makes the deadliest drug threat our country has ever faced, fentanyl, even deadlier,” said DEA Administrator Anne Milgram. “The DEA has seized mixtures of xylazine and fentanyl in 48 of the 50 states. The DEA laboratory system estimates that in 2022 he will have about 23% of the fentanyl powders seized by the DEA and his 7% of fentanyl tablets. % contained xylazine.”


Injecting fentanyl mixed with xylazine, a powerful tranquilizer used by veterinarians, can result in death or serious injury from drug intoxication. Necrosis—decay of skin and other human tissue—has been reported and can lead to amputation.

“Xylazine is not an opioid, so naloxone (Narcan) will not reverse its effects. Still, experts always recommend naloxone administration if someone may be suffering from drug addiction.

In southern Nevada, health officials said xylazine cases were “not yet rampant.” Subway police did not respond to eight News Now inquiries sent Tuesday.

According to the DEA, Mexican drug cartels are responsible for most of the fentanyl trafficked, primarily in the United States. The Sinaloa and Jalisco cartels get their chemicals from China.

“Trunk” is a powerful sedative drug approved for veterinary use by the US Food and Drug Administration. Xylazine is also called a “zombie drug”.

Only one death due to xylazine has been reported in 2020, according to the Southern Nevada Health District. Fentanyl was also present in deceased individuals.

“While current surveillance efforts in the Southern Nevada Health District indicate that cases of xylazine are not yet prevalent in the local drug supply, we are working to expand our agency’s surveillance capacity. This includes using the National Institute of Standards and Technology’s (NIST) Rapid Analysis of Drugs of Abuse and Related Compounds (RADaR) program to strengthen strategies and equip them with the tools they need to respond effectively. It includes equipping,” SNHD said on Tuesday.

The Nevada Hospital Association circulated the DEA’s concerns in weekly reports to keep hospitals informed of the problem.

8 News Now reported concerns about xylazine on February 27, when the Yuma County, Arizona Sheriff’s Office reported the concerns. Reports in Philadelphia, San Francisco, and New York have been public for quite some time, but the DEA’s warnings this week show that the spread of a mixture of fentanyl and xylazine can be seen in nearly every state.

In New York, concerns extend to heroin use, with drugs being tested for the presence of xylazine.

Since the February 27 report, the FDA has banned the importation of xylazine.

Leave a Reply